Male Fertility and Sperm Cryopreservation

Withdrawn before enrolling

Conditions studied: Fertility, SPERM, Cancer

In brief

PURPOSE: Primary objective: To assess the feasibility and outcomes of male fertility preservation by sperm freezing prior to starting treatment requiring alkylating agents and/or total body irradiation. Secondary objective: To assess pre- and post-treatment sperm production and hormonal status by measurement of serum anti-mullerian hormone (AMH), inhibin-B, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and androstendione.

Key facts

Study ID

NCT02431000

Run by

University of Tennessee

People needed

0

Starts

2015-05-01

Expected to finish

2020-06-30

Last updated by the study team

2020-11-13

Who can join

Age: 13 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• male, aged 13 years or older,
• diagnosed with cancer, but not yet undergoing therapy
• willing to participate in this clinical trial
• signed Informed consent document

You may not qualify if…

• under 13 years old
• have already begun Chemo or radiotherapy

Where it is running

• University of Tennessee Health Science Center Center for Reproductive Medicine, ROH, — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.